INTERNATIONAL PATENT: INHIBRX BIOSCIENCES, INC. FILES APPLICATION FOR "OX40 AGONIST THERAPY"

GENEVA, March 10 -- INHIBRX BIOSCIENCES, INC. (11025 N. Torrey Pines RoadSuite 140La Jolla, California 92037) filed a patent application (PCT/US2023/073279) for "OX40 AGONIST THERAPY" on Sep 01, 2023. With publication no. WO/2025/048860, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DIAZ-DE-DURANA, Yaiza (c/o Inhibrx Biosciences, Inc.11025 N. Torrey Pines RoadSuite 140La Jolla, California 92037), BAIS, Carlos Ernesto (c/o Inhibrx Biosciences, Inc.11025 N. Torrey Pines RoadSuite 140La Jolla, California 92037), ANDRIANOV,...